Plunkett Research Online: Big Pharma Split Corp

BIG PHARMA SPLIT CORP (PRM:TSE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions......



Big Pharma Split Corp
Ticker: PRM
Exchange: TSE
Parent Company: Harvest Portfolios Group Inc
Year Established:
Employees:
Fiscal Year Ends in

Phone: 416 649-4541
Fax: 416 649-4542
Address: 610 Chartwell Road
Suite 204
Oakville, ON L6J 4A5 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Asset Management
ContactsDescription

Michael KovacsCEO/Director/President/Secretary
Daniel LazzerCFO
See More
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions......See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: